Skip to main content
. 2015 Jul 1;10(3):1709–1715. doi: 10.3892/ol.2015.3442

Figure 3.

Figure 3.

Kaplan-Meier recurrence-free survival curves for 86 patients with breast carcinoma, grouped according to SMAD4 expression. SMAD4-negative patients demonstrated a significantly reduced recurrence-free survival rate compared with that of SMAD4-positive patients (P=0.028).